Published in State and Local Health Law Weekly, April 21st, 2005
These findings, highly unexpected in such a controlled environment, were published in the peer-reviewed, open-access journal BMC Psychiatry.
Dr. Bernard Favrat and colleagues, from the Institut Universitaire de Medecine Legale in Switzerland, were conducting a clinical trial into the effects of orally administered delta-9-tetrahydrocannibol (THC), the active ingredient in cannabis, when two of their male subjects...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of State and Local Health Law Weekly